+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 20Years +
All Genders
ID06497283

Effect of Binaural Sound on Remifentanil Dose During General Anesthesia Using Remimazolam

Led by Gangnam Severance Hospital · Updated on 2024-08-09

72

Participants Needed

1

Research Sites

3 weeks

Total Duration

AI-Summary

What this Trial Is About

Researchers are evaluating how binaural sound affects the dose of remifentanil needed during general anesthesia maintained with remimazolam. The study explores whether using binaural sound can reduce the amount of remifentanil required, improving anesthesia management. This randomized, placebo-controlled trial is sponsored by Gangnam Severance Hospital and includes adults aged 20 to 60 undergoing general anesthesia. Participants will be randomly assigned to one of two groups. One group will receive binaural sound through earphones during anesthesia, while the other group will wear headphones without sound as a placebo. The study focuses on the effects of these interventions during anesthesia on remifentanil dosage. During the anesthesia day, researchers will measure the amount of remifentanil given, monitor remimazolam dosing, and assess pain levels using a pain score from 0 to 10. Electroencephalography will also be conducted to evaluate brain activity. The study includes close monitoring to understand the impact of binaural sound on anesthesia management and patient comfort.

CONDITIONS

Brief Title

Binaural Sound for Remimazolam Maintenance

Research Team

H

Hyun-Chang Kim

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here